Governance Lessons for CRISPR/Cas9 from the Missed Opportunities of Asilomar

Ethics in Biology, Engineering and Medicine 6 (3-4):305-312 (2015)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,830

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Edited Genes and Slippery Slopes: Dilemmas in the Ethics of Gene Editing.John Harris - 2015 - Ethics in Biology, Engineering and Medicine 6 (3-4):281-284.
Crossing the Germline Barrier: The Three Genome Baby.Sheldon Krimsky - 2015 - Ethics in Biology, Engineering and Medicine 6 (3-4):237-261.
Cutting Eugenics Out of CRISPR-Cas9.Carolyn Brokowski, Marya Pollack & Robert Pollack - 2015 - Ethics in Biology, Engineering and Medicine 6 (3-4):263-279.
Trust in Science: CRISPR–Cas9 and the Ban on Human Germline Editing.Stephan Guttinger - 2018 - Science and Engineering Ethics 24 (4):1077-1096.
CRISPR Becomes Clearer.Andrew W. Torrance - 2017 - Hastings Center Report 47 (5):5-6.
Preface: CRISPR Technology, Gene Editing.Sheldon Krimsky - 2015 - Ethics in Biology, Engineering and Medicine 6 (3-4):235-236.
Biomedical Engineering Ethics.Philip Brey - 2012 - In Jan Kyrre Berg Olsen Friis, Stig Andur Pedersen & Vincent F. Hendricks (eds.), A Companion to the Philosophy of Technology. Malden, MA: Wiley-Blackwell. pp. 392–396.

Analytics

Added to PP
2019-02-16

Downloads
27 (#818,040)

6 months
9 (#464,038)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

References found in this work

No references found.

Add more references